Business Context and Reporting Period
This Form 8-K Current Report, dated August 31, 2023, pertains to Illumina, Inc. (ILMN). The filing primarily addresses a significant corporate governance event: the appointment of a permanent Chief Executive Officer (CEO) effective September 25, 2023.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the leadership transition at the executive level:
- CEO Appointment: Jacob Thaysen was appointed as permanent CEO and a member of the Board of Directors, effective September 25, 2023.
- Interim CEO Transition: Mr. Thaysen succeeds Charles Dadswell, who served as Interim CEO since June 11, 2023. Mr. Dadswell will continue in his role as Senior Vice President and General Counsel.
- Executive Background: Mr. Thaysen joins from Agilent Technologies, Inc., where he served as Senior Vice President, President of the Life Sciences and Applied Markets Group.
Compensation, Outlook, and Risks
The filing details the compensatory arrangements for the new CEO, which include significant cash and equity components designed to align interests with shareholders and compensate for forfeited benefits at his prior employer.
Compensation Structure
- Base Salary: $1,000,000 annually.
- Variable Cash Bonus: Eligible beginning in 2024 with a target opportunity of 125% of base salary.
- Annual Equity Awards: Beginning in 2024, grants with an aggregate value of $10,000,000 (70% Performance Stock Units, 30% Restricted Stock Units).
- One-Time Cash Payment: $500,000 to compensate for forfeited bonuses at Agilent (subject to clawback).
- One-Time Equity Grant: $3,500,000 to compensate for forfeited equity at Agilent (70% PSUs, 30% RSUs).
- Stock Purchase Match: A one-time RSU grant matching stock purchases made in the first 90 days, up to a maximum of $1,000,000.
- Relocation Stipend: $15,000 monthly until relocation or June 30, 2024.
Change in Control Severance
A Change in Control Severance Agreement provides for double the sum of base salary and target bonus, pro rata bonus, 24 months of health benefits, full equity vesting, and outplacement services if employment is terminated without Cause or for Good Reason within two years of a Change in Control.
Outlook and Risks: The filing does not provide specific financial guidance, management commentary on market conditions, or a discussion of operational risks beyond the standard severance contingencies.
Investor Verification Checklist
- Verify the commencement date of Jacob Thaysen's tenure (September 25, 2023) and the transition plan from the interim CEO.
- Review the full terms of the Offer Letter (Exhibit 10.1) and Change in Control Severance Agreement (Exhibit 10.2) for specific vesting schedules and clawback provisions.
- Assess the impact of the $13.5 million in one-time compensation ($500k cash + $3.5M equity + up to $1M match) on near-term compensation expenses.
- Monitor the press release (Exhibit 99.1) for any additional strategic context regarding the leadership change.